VIGEO THERAPEUTICS

Vigeo Therapeutics is a clinical-stage biopharmaceutical company developing novel therapeutic agents intended to treat an advanced malignant tumor that can effectively treat multiple types of cancer and improve the lives of patients. The company building a first-in-class drug discovery pipeline that reprograms the tumor immune microenvironment (TIME). They plan to commence multiple combination studies to evaluate VT1021 in combination with chemotherapies and/or anti-PD-1 antibodies. The company was established in 2011 and is headquartered in Cambridge, Massachusetts.

#SimilarOrganizations #People #Event #Website #More

VIGEO THERAPEUTICS

Social Links:

Linkedin

Twitter

Industry:

Biotechnology Health Care Therapeutics

Founded:

2011-01-01

Address:

Cambridge, Massachusetts, United States

Country:

United States

Website Url:

http://www.vigeotherapeutics.com

Total Employee:

11+

Status:

Active

Contact:

617-945-0385

Email Addresses:

[email protected]

Total Funding:

10 M USD

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API WordPress Content Delivery Network Sitelinks Search Box Microsoft Exchange Online Office 365 Mail

Similar Organizations

cascadian-therapeutics-logo

Cascadian Therapeutics

Cascadian Therapeutics is a bio-pharmaceutical company that researches, develops, and sells therapeutic products for treatment of cancer.

cti-biopharma-logo

CTI BioPharma

CTI BioPharma is a biopharmaceutical company developing oncology products for the treatment of cancer.

palatin-technologies-logo

Palatin Technologies

Palatin Technologies, a biopharmaceutical company, develops targeted receptor specific peptide therapeutics for the treatment of diseases.

transition-therapeutics-logo

Transition Therapeutics

Transition Therapeutics is a biopharmaceutical company developing novel therapeutics for disease indications with large markets.

prescient-therapeutics-logo

Prescient Therapeutics

Prescient Therapeutics is a biopharmaceutical company, discovers and develops novel immunotherapeutic products for the treatment of chronic.

Current Advisors List

jason-dinges_image

Jason Dinges Member of the Board of Directors @ Vigeo Therapeutics
Board_member

Current Employees Featured

daniel-geffken_image

Daniel Geffken
Daniel Geffken Interim Chief Financial Officer @ Vigeo Therapeutics
Interim Chief Financial Officer
2017-11-01

randy-watnick_image

Randy Watnick
Randy Watnick Co-Founder @ Vigeo Therapeutics
Co-Founder

not_available_image

Jim Mahoney
Jim Mahoney Chief Executive Officer @ Vigeo Therapeutics
Chief Executive Officer
2021-02-01

not_available_image

Peter B. Finn
Peter B. Finn Director @ Vigeo Therapeutics
Director

Founder

jing-watnick_image

Jing Watnick

randy-watnick_image

Randy Watnick

Key Employee Changes

Date	New article
2021-09-21	Vigeo Therapeutics Provides Clinical Update for Lead Asset VT1021 and Welcomes New Chief Executive Officer

Official Site Inspections

http://www.vigeotherapeutics.com Semrush global rank: 2.4 M Semrush visits lastest month: 7.62 K

Host Informations
Whois Informations

Loading ...

More informations about "Vigeo Therapeutics" on Search Engine